Obesity and Metabolic Disorder
Obesity is an uncharacteristic or excessive body fat accretion. It is recognized by a body mass index (BMI) of 30 or higher. Metabolic syndrome is accompanying with the risk of developing cardiovascular disease and Type 2 diabetes. Insulin conflict, metabolic disease, and pre-diabetes are closely interconnected to one another and have overlapping aspects. The syndrome is thought to be caused by an underlying disorder of energy exploitation and storage. The source of the syndrome is an area of on-going medical research. Complications triggered comprise cardiovascular disorders (particularly in people with excess abdominal fat), diabetes mellitus, assured cancers, cholelithiasis, fatty liver, cirrhosis, osteoarthritis, reproductive syndromes in men and women, psychological disorders, and, for people with BMI ≥ 35, premature death.
- Sarcopenic Obesity
- Lipid Control in Diabetes and Metabolic Syndrome
- Quantitative trait and Obesity
- Obstructive Sleep Apnea
- Metabolic Bone Disease
Related Conference of Obesity and Metabolic Disorder
Obesity and Metabolic Disorder Conference Speakers
Recommended Sessions
- Clinical Pathology
- Animal and Plant Biochemistry
- Antibody Engineering & Therapeutics
- Biochemistry in Cancer research
- Biomathematics and Biostatistics
- Biophysical techniques
- Biophysics
- Cellular and Molecular Biology
- Clinical & Forensic Biochemistry
- Computational Chemistry and Chemical Biology
- Environmental Biochemistry
- Enzymology and Biochemistry
- Epidemiology
- Food and Nutritional Biochemistry
- Gene Expression and Genetic Engineering
- Improving Rare Disease Diagnosis with Metabolomics
- Industrial & Structural Biochemistry
- Metabolic Biochemistry
- Metabolomic Technology and Bioinformatics
- Metabolomics in Ophthalmology
- Obesity and Metabolic Disorder
- Pharmaceutical Biochemistry
- Protein Engineering
Related Journals
Are you interested in
- 3-D Structure Determination - Structural Biology 2025 (Germany)
- Advancements in structural Biology - Structural Biology 2025 (Germany)
- Biochemistry - Glycobiology 2025 (Germany)
- Biochemistry and Biophysics - Structural Biology 2025 (Germany)
- Computational Approach in Structural Biology - Structural Biology 2025 (Germany)
- Drug Designing and Biomarkers - Structural Biology 2025 (Germany)
- Evolution of Glycan Diversity - Glycobiology 2025 (Germany)
- Frontiers in Structural Biology - Structural Biology 2025 (Germany)
- Gene regulation and Cell Signalling - Structural Biology 2025 (Germany)
- Genomics and Metabolomics - Glycobiology 2025 (Germany)
- Glycans in Diseases and Therapeutics - Glycobiology 2025 (Germany)
- Glycans in Drug Design - Glycobiology 2025 (Germany)
- Glycan’s - Glycobiology 2025 (Germany)
- Glycobiology - Glycobiology 2025 (Germany)
- Glycochemistry - Glycobiology 2025 (Germany)
- Glycoimmunology - Glycobiology 2025 (Germany)
- Glycoinformatics - Glycobiology 2025 (Germany)
- Glycolipids and Glycopeptides - Glycobiology 2025 (Germany)
- Glyconeurobiology - Glycobiology 2025 (Germany)
- Glycopathology - Glycobiology 2025 (Germany)
- Glycosience - Glycobiology 2025 (Germany)
- Hybrid approaches in Structure prediction - Structural Biology 2025 (Germany)
- Molecular Biology - Structural Biology 2025 (Germany)
- Molecular biology techniques - Structural Biology 2025 (Germany)
- Molecular Modelling and Dynamics - Structural Biology 2025 (Germany)
- Proteoglycan and Sialic acid - Glycobiology 2025 (Germany)
- Proteomics and Genomics - Structural Biology 2025 (Germany)
- Recent Advances in Glycobiology - Glycobiology 2025 (Germany)
- Sequencing Analysis - Structural Biology 2025 (Germany)
- Structural Bioinformatics - Structural Biology 2025 (Germany)
- Structural Biology - Structural Biology 2025 (Germany)
- Structural Biology Databases - Structural Biology 2025 (Germany)
- Structural Biology in Cancer Research - Structural Biology 2025 (Germany)
- Structural Enzymology - Structural Biology 2025 (Germany)
- Synthesis and Biological Role of Glycans - Glycobiology 2025 (Germany)